Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)

Clinical trial NCT00991744 · SUSPENDED

Trial details

NCT number: NCT00991744
Sponsor: Nordic Society for Pediatric Hematology and Oncology
Status: SUSPENDED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia

Start date: 2009-01-01
Primary completion: 2018-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.